Get started
Author

Alexa Childs

Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres
2019 · Melissa Frizziero, Xin Wang, et al. · World Journal of Gastroenterology · 75
PDF
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)
2018 · Andreas Wicki, Nicholas Brown, et al. · European Journal of Cancer · 66
PDF
Immunotherapy for hepatocellular carcinoma
2024 · Alexa Childs, Gloryanne Aidoo-Micah, et al. · JHEP Reports · 58
PDF
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas
2016 · Angela Lamarca, Thomas Walter, et al. · JNCI Journal of the National Cancer Institute · 46
Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit
2021 · Alexa Childs, Nekisa Zakeri, et al. · British Journal of Cancer · 42
PDF
Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours
2016 · Alexa Childs, Clare Vesely, et al. · British Journal of Cancer · 40
PDF
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours
2019 · Francesca M. Rizzo, Clare Vesely, et al. · British Journal of Cancer · 35
PDF
Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours
2016 · Alexa Childs, Amy Kirkwood, et al. · Endocrine Related Cancer · 26
PDF
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms
2021 · Alexa Childs, Christopher D Steele, et al. · Endocrine Related Cancer · 14
PDF
Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2022 · Clare Vesely, Yien Ning Sophia Wong, et al. · Clinical Cancer Research · 11
A Prospective Observational Cohort Study for Newly Diagnosed Osteosarcoma Patients in the UK: ICONIC Study Initial Results
2024 · Alexa Childs, Craig Gerrand, et al. · Cancers · 6
PDF
Hepatocellular Carcinoma: Treatment
2019 · Alexa Childs, Tim Meyer · Wiley eBooks · 3
Mixed adeno-neuroendocrine carcinoma (MANEC) of the gastroenteropancreatic (GEP) tract: A multicentre retrospective study
2017 · M. Frizziero, X. Wang, et al. · Annals of Oncology · 3
A phase 1 first-in-human (FIH) dose-escalation (DE) study of the oral dual PI3K/mTOR inhibitor PQR309 in patients (pts) with advanced solid tumors: Final DE results.
2015 · Rebecca Sophie Kristeleit, Nicholas F. Brown, et al. · Journal of Clinical Oncology · 3
BNT326-01: A Phase 1b/2 trial of BNT326/YL202 (HER3 ADC) as monotherapy and in combination with pumitamig (anti-PD-L1 × VEGF bsAb) in patients with advanced solid tumors.
2026 · Siqing Fu, David James Pinato, et al. · Journal of Clinical Oncology · 2
Status of hepatocellular cancer in Europe.
2013 · Alexa Childs, James O'Beirne, et al. · PubMed · 2
Fine needle aspirates characterise the hepatocellular carcinoma immune niche to predict immune checkpoint inhibitor outcomes
2025 · Gloryanne Aidoo-Micah, Stephanie Kucykowicz, et al. · JHEP Reports · 1
PDF
Data from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2023 · Clare Vesely, Yien Ning Sophia Wong, et al. · 1
Systematic Evaluation of the Immune Microenvironment of Neuroendocrine Tumors (NET)
2018 · Clare Vesely, A. Childs, et al. · UCL Discovery (University College London) · 1
2389 Detection of SSTR2 and 5 expression in circulating tumour cells from patients with neuroendocrine tumours
2015 · A. Childs, C. Vesely, et al. · European Journal of Cancer · 1
Abstract CT310: First-in-man (FIM) pharmacodynamic (PD) and pharmacokinetic (PK) phase I trial of PQR309 in advanced solid tumors
2015 · Andreas Wicki, Cristiana Sessa, et al. · Cancer Research · 1
169P Presentation, imaging and 30-day outcomes of immune-checkpoint inhibitor-induced myocarditis: Real-world experience from the United Kingdom
2025 · Y. Wang, J. Knott, et al. · Immuno-Oncology Technology
Table 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2025 · Clare Vesely, Yien Ning Sophia Wong, et al.
Figure 2 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2025 · Clare Vesely, Yien Ning Sophia Wong, et al.
Figure 1 from Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
2025 · Clare Vesely, Yien Ning Sophia Wong, et al.
Works count: 58
Citation count: 437
H-index: 10
I10-index: 10
Year
Topic
Type